Literatur
- 1
Greenwood BM, Bojang K, Whitty JM, Targett GA.
Malaria.
Lancet.
2005;
365
1487-1498
- 2
Mandi G, Witte S, Meissner P. et al. .
Safety of the combination of chloroquine and methylene blue in healthy adult men with
G6PD deficiency from rural Burkina Faso.
Trop Med Int Health.
2005;
10
32-38
- 3
Meissner P, Mandi G, Coulibaly B. et al. .
Methylene blue for malaria in Africa: results from a dose-finding study in combination
with chloroquine.
Malar J.
2006;
5
84
- 4
Meissner P, Mandi G, Witte S. et al. .
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated
falciparum malaria in young children of Burkina Faso.
Malar J.
2005;
4
46
- 5
Müller O.
History and state of global malaria control.
Nova Acta Leopold.
2000;
80
127-149
- 6 Müller O. Malaria. In: Razum 0, Zeeb H, Laaser U (Hrsg.). Globalisierung - Gerechtigkeit
- Gesundheit, Einführung in International Public Health. Bern: Verlag Hans Huber 2006:
267-278
- 7
Rengelshausen J, Burhenne J, Fröhlich M. et al. .
Pharmacokinetic interaction of chloroquine and methylene blue combination against
malaria.
Eur J Clin Pharmacol.
2004;
60
709-715
- 8 Sanon M, Mandi G, De M Allegri. et al. .Attitudes regarding colouration effects
associated with methylene blue malaria treatment in a rural community of Burkina Faso. Curare
(in press)
- 9
Schirmer RH, Coulibaly B, Stich A. et al. .
Methylene blue as an antimalarial agent - past and future.
Redox Rep.
2003;
8
272-276
- 10
Schirmer RH.
Medikamente für die Armen.
Spektrum der Wissenschaft.
2004;
12
110-113
Korrespondenz
PD Dr. med. Olaf Müller
Abteilung Tropenhygiene und Öffentliches Gesundheitswesen
Universitätsklinikum Heidelberg
Ruprecht-Karls-Universität Heidelberg
Im Neuenheimer Feld 324
69120 Heidelberg
Email: Olaf.Mueller@urz.uni-heidelberg.de
